¼¼°èÀÇ µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀå
Animal Blood & Blood Components
»óǰÄÚµå : 1791467
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 174 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,550,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 2¾ï 6,320¸¸ ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 1¾ï 5,820¸¸ ´Þ·¯·Î ÃßÁ¤µÈ µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£¿¡ CAGR 8.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 2¾ï 6,320¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ µ¿¹° Ç÷¾× ¼ººÐÀº CAGR 10.6%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 5,570¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. µ¿¹° ÀüÇ÷ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 6.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4,160¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÑÆí, Áß±¹Àº CAGR 8.5%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÈ´Ù

¹Ì±¹ÀÇ µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀåÀº 2024³â¿¡´Â 4,160¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 8.5%·Î ¼ºÀåÇÏ¿© 2030³â±îÁö ¿¹Ãø ½ÃÀå ±Ô¸ð 4,180¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 8.3%¿Í 7.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.9%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

´Ù¾çÇÑ »ê¾÷¿¡¼­ µ¿¹°ÀÇ Ç÷¾×°ú Ç÷¾× ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

µ¿¹°ÀÇ Ç÷¾×°ú ±× ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä´Â ÀǾàǰ, µ¿¹°»ç·á, ½Äǰ °¡°ø, Áø´Ü µî ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµÇ±â ¶§¹®¿¡ ´Ù¾çÇÑ »ê¾÷¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ç÷Àå, Çì¸ð±Û·Îºó, Ç÷û ´Ü¹éÁú°ú °°Àº µ¿¹° Ç÷¾× À¯µµÃ¼ÀÇ ¹é½Å, Ä¡·á Á¦Ç°, ¹ÙÀÌ¿À ÀǾàǰ »ý»ê¿¡ ´ëÇÑ »ç¿ë Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, µ¿¹°»ç·á »ê¾÷µµ Áß¿äÇÑ ¼ÒºñÀÚ·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, Ç÷¾× ½Ä»ç ¹× Ç÷Àå ´Ü¹éÁúÀº °¡ÃàÀÇ ¿µ¾ç°ú ¼ºÀåÀ» Çâ»ó½Ã۱â À§ÇÑ °í´Ü¹é ¿µ¾ç º¸ÃæÁ¦·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Äǰ °¡°ø ¾÷°è´Â dzºÎÇÑ ¾Æ¹Ì³ë»ê°ú ´Ü¹éÁú ÇÔ·®À» ÀÌ¿ëÇÏ¿© ±â´É¼º ½Äǰ ¹× ¿µ¾ç º¸ÃæÁ¦ Á¦Á¶¿¡ µ¿¹°ÀÇ Ç÷¾× ¼ººÐÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. Áö¼Ó °¡´ÉÇÑ ÀÚ¿ø Ȱ¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ µ¿¹° Ç÷¾× Á¦Ç°º°·Î Çõ½ÅÀûÀÎ ¿ëµµ¸¦ ã°í, Æó±â¹°À» ÁÙÀ̰í, µ¿¹° °¡°ø¿¡¼­ ¾òÀ» ¼ö ÀÖ´Â °¡Ä¡¸¦ ±Ø´ëÈ­Çϱâ À§ÇØ ¾÷°è°¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀº ¾î¶»°Ô ½ÃÀå Çõ½ÅÀ» ÃËÁøÇϰí Àִ°¡?

ó¸® ¹× ºÐ¸® ±â¼úÀÇ ±â¼ú ¹ßÀüÀº µ¿¹° Ç÷¾× ¼ººÐÀÇ »ý»ê°ú ÀÀ¿ë¿¡ Çõ¸íÀ» °¡Á®¿Ô½À´Ï´Ù. ºÐȹ ¹× Á¤Á¦ °øÁ¤ÀÇ ±â¼ú Çõ½ÅÀº ±â´ÉÀû Ư¼ºÀÌ °­È­µÈ °íºÎ°¡°¡Ä¡ ´Ü¹éÁú°ú »ý¸®È°¼º È­ÇÕ¹°À» ÃßÃâÇÏ¿© »ý¸í°øÇÐ ¹× Á¦¾à ºÐ¾ßÀÇ Æ¯¼ö ¿ëµµ¿¡ ÀûÇÕÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÷´Ü ¸ê±Õ ¹× º¸Á¸ ±â¼úÀ» äÅÃÇÏ¿© Ç÷¾× À¯·¡ Á¦Ç°ÀÇ º¸Á¸ ±â°£°ú ¾ÈÁ¤¼ºÀ» Çâ»ó½Ã۰í, ÃÖÁ¾ »ç¿ëÀÚ¿¡°Ô ǰÁú°ú È¿´ÉÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, »ý¸í°øÇÐ ¹× ºÐÀÚ»ý¹°ÇÐ ¿¬±¸¸¦ ÅëÇØ ¸é¿ª±Û·ÎºÒ¸°ÀÌ Ç³ºÎÇÑ Ç÷Àå ¹× µ¿¹°Ç÷¾× À¯·¡ »ý¸®È°¼º ÆéŸÀ̵å¿Í °°Àº »õ·Î¿î Á¦Ç° °³¹ßÀ» ÃËÁøÇÏ¿© ¸é¿ª °Ç°­, »óó Ä¡À¯, ¿µ¾çº¸ÃæÁ¦ µî¿¡ ÀÀ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû Áøº¸°¡ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó Á¦Á¶¾÷üµéÀº Á¦Ç°ÀÇ Àϰü¼º Çâ»ó, ó¸® ºñ¿ë Àý°¨, °¢ Áö¿ªÀÇ ±ÔÁ¦ ¿ä°ÇÀ» ÃæÁ·Çϱâ À§ÇÑ ¾ÈÀü ±âÁØ °­È­¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀå¿¡´Â ¾î¶² °úÁ¦¿Í ±âȸ°¡ Á¸ÀçÇÒ±î?

µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀåÀº ±ÔÁ¦ Àå¾Ö¹°, À±¸®Àû ¹®Á¦, ¿ø·á °ø±ÞÀÇ ºÒ±ÕÇü µî ¿©·¯ °¡Áö ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ ½Äǰ »ê¾÷°ú Á¦¾à »ê¾÷¿¡¼­ µ¿¹°¼º ¿ø·áÀÇ ¼öÁý, °¡°ø, »ç¿ëÀ» ±ÔÁ¤ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå °ü°èÀڵ鿡°Ô ÄÄÇöóÀ̾𽺠À̽´°¡ µÇ°í ÀÖ½À´Ï´Ù. µ¿¹° º¹Áö ¹× Ç÷¾×Á¦Á¦ Á¶´Þ°ú °ü·ÃµÈ À±¸®Àû ¹®Á¦µµ ¾÷°è ÀÌÇØ°ü°èÀڵ鿡°Ô º¸´Ù Åõ¸íÇϰí Áö¼Ó °¡´ÉÇÑ Á¶´Þ °üÇàÀ» äÅÃÇÒ °ÍÀ» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿À¿° ¹× Áúº´ ÀüÆÄÀÇ ÀáÀçÀû À§ÇèÀº ¾ö°ÝÇÑ Ç°Áú °ü¸® Á¶Ä¡¸¦ ÇÊ¿ä·Î Çϸç, ¾÷¹«ÀÇ º¹À⼺À» ´õ¿í Áõ°¡½Ãŵ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ µµÀüÀº ±â¼ú Çõ½Å°ú ½ÃÀå Â÷º°È­ÀÇ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ´ëü ´Ü¹éÁú °ø±Þ¿ø¿¡ ´ëÇÑ °ü½É Áõ°¡, Ŭ¸° ¶óº§ ¹× Áö¼Ó °¡´ÉÇÑ ¿ø·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »ýü Àç·á ¹× Àç»ý ÀÇÇÐ ºÐ¾ßÀÇ ¿¬±¸ È®´ë´Â µ¿¹° Ç÷¾× À¯·¡ Á¦Ç°¿¡ ´ëÇÑ À¯¸ÁÇÑ ¼ºÀå ¼ö´ÜÀ» Á¦°øÇÕ´Ï´Ù. ģȯ°æ °¡°ø ±â¼ú°ú °­·ÂÇÑ ÃßÀû ½Ã½ºÅÛ¿¡ ÅõÀÚÇÏ´Â ±â¾÷Àº ÁøÈ­ÇÏ´Â ½ÃÀå¿¡¼­ »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ´Â À¯¸®ÇÑ À§Ä¡¿¡ ÀÖ½À´Ï´Ù.

µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

µ¿¹° Ç÷¾× ¹× Ç÷¾× ¼ººÐ ½ÃÀåÀÇ ¼ºÀåÀº °í´Ü¹é µ¿¹°»ç·á ¼ö¿ä Áõ°¡, ÀǾàǰ¿¡ ´ëÇÑ Àû¿ë È®´ë, ½Äǰ °¡°ø¿¡ ´ëÇÑ È°¿ë È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁý´Ï´Ù. ¼¼°è Àα¸ Áõ°¡¿Í È¿À²ÀûÀÎ Ãà»ê¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó µ¿¹°ÀÇ °Ç°­°ú »ý»ê¼ºÀ» Çâ»ó½ÃŰ´Â Ç÷¾× ±â¹Ý »ç·á ÷°¡Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾à¾÷°è°¡ ¹é½Å »ý»ê, ¼¼Æ÷¹è¾ç ¹èÁö, ¹ÙÀÌ¿À ÀǾàǰ °³¹ßÀ» À§ÇØ Ç÷¾× À¯·¡ ´Ü¹éÁú¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ´Â °Íµµ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ, µ¿¹°ÀÇ Ç÷¾× ¼ººÐÀ» ÇÔÀ¯ÇÑ ±â´É¼º ½Äǰ ¹× °Ç°­±â´É½Äǰ Áõ°¡ Ãß¼¼µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áö¼Ó °¡´ÉÇÑ ÀÚ¿ø ÀÌ¿ëÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í °¡°ø ±â¼úÀÇ ¹ßÀüÀº ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

À¯Çü(µ¿¹° Ç÷¾× ¼ººÐ, µ¿¹° ÀüÇ÷), µ¿¹° »çÀÌÁî(´ëÇü µ¿¹°, ¼ÒÇü µ¿¹°), ¿ëµµ(ºóÇ÷ ¿ëµµ, ¿Ü°ú ¿ëµµ, ÃâÇ÷¼º Áúȯ ¿ëµµ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Animal Blood & Blood Components Market to Reach US$263.2 Million by 2030

The global market for Animal Blood & Blood Components estimated at US$158.2 Million in the year 2024, is expected to reach US$263.2 Million by 2030, growing at a CAGR of 8.9% over the analysis period 2024-2030. Animal Blood Components, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$155.7 Million by the end of the analysis period. Growth in the Animal Whole Blood segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.6 Million While China is Forecast to Grow at 8.5% CAGR

The Animal Blood & Blood Components market in the U.S. is estimated at US$41.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$41.8 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Animal Blood & Blood Components Market - Key Trends & Drivers Summarized

Why Is Demand for Animal Blood & Blood Components Increasing Across Various Industries?

The demand for animal blood and its components is rising across multiple industries due to its wide-ranging applications in pharmaceuticals, animal feed, food processing, and diagnostics. The increasing use of animal blood derivatives such as plasma, hemoglobin, and serum proteins in the production of vaccines, therapeutic products, and biopharmaceuticals is a key factor driving market growth. The animal feed industry has also emerged as a significant consumer, with blood meal and plasma proteins being used as high-protein dietary supplements to enhance livestock nutrition and growth. In addition, the food processing industry is incorporating animal blood components in the production of functional foods and nutritional supplements, leveraging their rich amino acid and protein content. The growing awareness of sustainable resource utilization is further encouraging industries to explore innovative applications of animal blood by-products, reducing waste and maximizing value from animal processing.

How Are Technological Advancements Driving Innovation in the Market?

Technological advancements in processing and separation techniques are revolutionizing the production and application of animal blood components. Innovations in fractionation and purification processes are enabling the extraction of high-value proteins and bioactive compounds with enhanced functional properties, making them suitable for specialized applications in biotechnology and pharmaceuticals. The adoption of advanced sterilization and preservation technologies is also improving the shelf life and stability of blood-derived products, ensuring their quality and efficacy for end-users. Additionally, research in biotechnology and molecular biology is facilitating the development of novel products such as immunoglobulin-rich plasma and bioactive peptides derived from animal blood, offering potential benefits for immune health, wound healing, and nutraceutical applications. As these technological advancements continue to evolve, manufacturers are focusing on improving product consistency, reducing processing costs, and enhancing safety standards to meet regulatory requirements across different regions.

What Challenges and Opportunities Exist in the Animal Blood & Blood Components Market?

The animal blood and blood components market faces several challenges, including regulatory hurdles, ethical concerns, and variability in raw material supply. Stringent regulatory frameworks governing the collection, processing, and use of animal-derived materials, particularly in the food and pharmaceutical industries, present compliance challenges for market players. Ethical concerns related to animal welfare and the sourcing of blood products have also prompted industry stakeholders to adopt more transparent and sustainable sourcing practices. Additionally, the potential risks of contamination and disease transmission require rigorous quality control measures, further adding to operational complexities. However, these challenges present opportunities for innovation and market differentiation. The increasing focus on alternative protein sources, growing demand for clean-label and sustainable ingredients, and the expansion of research in biomaterials and regenerative medicine offer promising growth avenues for animal blood-derived products. Companies investing in eco-friendly processing technologies and robust traceability systems are well-positioned to capitalize on emerging opportunities in this evolving market.

What Are the Key Factors Driving Growth in the Animal Blood & Blood Components Market?

The growth in the Animal Blood & Blood Components market is driven by several factors, including the rising demand for high-protein animal feed, expanding applications in pharmaceuticals, and increasing utilization in food processing. The growing global population and the rising need for efficient livestock production are fueling the demand for blood-based feed additives that enhance animal health and productivity. The pharmaceutical industry's increasing reliance on blood-derived proteins for vaccine production, cell culture media, and biopharmaceutical development is another major growth driver. Additionally, the growing trend of functional foods and dietary supplements incorporating animal blood components is contributing to market expansion. Government initiatives promoting sustainable resource utilization and advancements in processing technologies are expected to further accelerate market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Animal Blood & Blood Components market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Animal Blood Components, Animal Whole Blood); Animal Size (Large Animals, Small Animals); Application (Anemia Application, Surgery Application, Bleeding Disorders Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â